218 related articles for article (PubMed ID: 6378283)
1. Practical breast carcinoma cell kinetics: review and update.
Meyer JS; McDivitt RW; Stone KR; Prey MU; Bauer WC
Breast Cancer Res Treat; 1984; 4(2):79-88. PubMed ID: 6378283
[TBL] [Abstract][Full Text] [Related]
2. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
3. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
[TBL] [Abstract][Full Text] [Related]
4. S-phase fractions of breast carcinomas. Relationships to morphology, estrogen and progesterone receptors, and early recurrence.
Meyer JS; Bauer WC; Stevens SC; Rao BR; White WL
Bull Cancer; 1978; 65(4):449-54. PubMed ID: 747801
[TBL] [Abstract][Full Text] [Related]
5. A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers.
McDivitt RW; Stone KR; Craig RB; Palmer JO; Meyer JS; Bauer WC
Cancer; 1986 Jan; 57(2):269-76. PubMed ID: 3942959
[TBL] [Abstract][Full Text] [Related]
6. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons and correlations.
Meyer JS; Coplin MD
Am J Clin Pathol; 1988 May; 89(5):586-95. PubMed ID: 3358366
[TBL] [Abstract][Full Text] [Related]
7. Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer.
Kallioniemi OP; Hietanen T; Mattila J; Lehtinen M; Lauslahti K; Koivula T
Eur J Cancer Clin Oncol; 1987 Mar; 23(3):277-82. PubMed ID: 3595689
[TBL] [Abstract][Full Text] [Related]
8. Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy.
Meyer JS; Wittliff JL
Int J Cancer; 1991 Jan; 47(2):213-20. PubMed ID: 1988366
[TBL] [Abstract][Full Text] [Related]
9. Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.
Meyer JS; Province M
Breast Cancer Res Treat; 1988 Oct; 12(2):191-204. PubMed ID: 3242648
[TBL] [Abstract][Full Text] [Related]
10. Cell kinetic analysis of human breast carcinomas.
Meyer JS
Monogr Pathol; 1984; (25):45-58. PubMed ID: 6377051
[TBL] [Abstract][Full Text] [Related]
11. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.
Haghbin M; McCue PA; Mansfield CM; Komarnicky LT; Benammar A; Schwartz GF
Am J Clin Oncol; 1996 Feb; 19(1):54-8. PubMed ID: 8554037
[TBL] [Abstract][Full Text] [Related]
12. Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.
Meyer JS
NCI Monogr; 1986; (1):25-8. PubMed ID: 3774013
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.
Helin HJ; Helle MJ; Kallioniemi OP; Isola JJ
Cancer; 1989 May; 63(9):1761-7. PubMed ID: 2649227
[TBL] [Abstract][Full Text] [Related]
14. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.
Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Lehtinen M; Koivula T
Cancer; 1988 Nov; 62(10):2183-90. PubMed ID: 3179930
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.
Visscher DW; Zarbo RJ; Jacobsen G; Kambouris A; Talpos G; Sakr W; Crissman JD
Lab Invest; 1990 Mar; 62(3):370-8. PubMed ID: 1690316
[TBL] [Abstract][Full Text] [Related]
18. Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study.
Meyer JS; Prey MU; Babcock DS; McDivitt RW
Lab Invest; 1986 Jan; 54(1):41-51. PubMed ID: 3941541
[TBL] [Abstract][Full Text] [Related]
19. DNA flow cytometry of breast carcinoma after acetic-acid fixation.
Meyer JS; Micko S; Craver JL; McDivitt RW
Cell Tissue Kinet; 1984 Mar; 17(2):185-97. PubMed ID: 6697373
[TBL] [Abstract][Full Text] [Related]
20. DNA index and cell cycle analysis of primary breast cancer and synchronous axillary lymph node metastases.
Feichter GE; Kaufmann M; Müller A; Haag D; Eckhardt R; Goerttler K
Breast Cancer Res Treat; 1989 Jan; 13(1):17-22. PubMed ID: 2706325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
